High-density lipoprotein cholesterol-raising strategies

被引:14
作者
Kuvin, JT [1 ]
Alsheikh-Ali, AA [1 ]
Karas, RH [1 ]
机构
[1] Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USA
关键词
apolipoprotein; cholesterol; coronary artery disease; HDL;
D O I
10.1097/01.fjc.0000199684.20578.7c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a distinct inverse relationship between high-density lipoprotein cholesterol (HDL-C) and cardiovascular disease risk. HDL-C mediates cholesterol efflux from the vasculature and promotes anti-oxidant, anti-inflammatory, and anti-thrornbotic effects. There are multiple lifestyle and therapeutic interventions that raise HDL-C, and there is increasing evidence that these interventions improve cardiovascular outcomes. Recent findings regarding the role of HDL-C in cholesterol metabolism offer new strategies designed to target atherosclerosis. This review highlights the utility of existing HDL-C-raising strategies and examines new potential therapies.
引用
收藏
页码:196 / 204
页数:9
相关论文
共 106 条
[1]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[2]   Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene [J].
Agerholm-Larsen, B ;
Nordestgaard, BG ;
Steffensen, R ;
Jensen, G ;
Tybjærg-Hansen, A .
CIRCULATION, 2000, 101 (16) :1907-1912
[3]   EFFECT OF A MODIFIED, WELL-TOLERATED NIACIN REGIMEN ON SERUM TOTAL CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND THE CHOLESTEROL TO HIGH-DENSITY LIPOPROTEIN RATIO [J].
ALDERMAN, JD ;
PASTERNAK, RC ;
SACKS, FM ;
SMITH, HS ;
MONRAD, ES ;
GROSSMAN, W .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (12) :725-729
[4]   High-density lipoprotein cholesterol in the cardiovascular equation: Does the "Good" still count? [J].
Alsheikh-Ali, AA ;
Kuvin, JT ;
Karas, RH .
ATHEROSCLEROSIS, 2005, 180 (02) :217-223
[5]   Risk of adverse events with fibrates [J].
Alsheikh-Ali, AA ;
Kuvin, JT ;
Karas, RH .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) :935-+
[6]  
ALSHEIKHALI AA, 2004, CIRCULATION S3, V110, P813
[7]  
[Anonymous], 1978, Atherosclerosis, V30, P239
[8]  
[Anonymous], DIABETES CARE S1
[9]   Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S [J].
Ballantyne, CM ;
Olsson, AG ;
Cook, TJ ;
Mercuri, MF ;
Pedersen, TR ;
Kjekshus, J .
CIRCULATION, 2001, 104 (25) :3046-3051
[10]   Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy [J].
Ballantyne, CM ;
Herd, JA ;
Ferlic, LL ;
Dunn, JK ;
Farmer, JA ;
Jones, PH ;
Schein, JR ;
Gotto, AM .
CIRCULATION, 1999, 99 (06) :736-743